title: [Cardiovascular changes during alpha-2 agonist treatment of opiate withdrawal syndrome].
authors.forename: G
authors.initials: G
authors.lastname: Rubio
authors.forename: F
authors.initials: F
authors.lastname: López-Muñoz
authors.forename: C
authors.initials: C
authors.lastname: Alamo
authors.forename: A
authors.initials: A
authors.lastname: Arias
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D003000:Clonidine / Q000494:pharmacology; D016316:Guanfacine / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects*; D003932:Heroin / Q000009:adverse effects*; D006556:Heroin Dependence / Q000628:therapy*; D051381:Rats; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D013997:Time Factors
chemical_list: D000316:Adrenergic alpha-Agonists; D016316:Guanfacine; D003932:Heroin; D003000:Clonidine
vernacular_title: Alteraciones cardiovasculares durante el tratamiento del síndrome de abstinencia a opiáceos con fármacos alfa-2 agonistas.